TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24304033

Group type: EXPERIMENTAL
Intervention: Routine pre‐ and postnatal visits with an International Board Certified Lactation Consultant (IBCLC)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Electronically prompted guidance from prenatal care providers (EP group)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: EP+LC combined
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 67
Study: 23186566

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 5% potassium nitrate
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 5% calcium sodium phosphosilicate with fused silica
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 3.85% amine fluoride
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 149
Study: 20381652

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 850

Group type: COMPARATOR
Intervention: UFH plus protamine
Number of subjects: 850
Study: 18558913

Group type: EXPERIMENTAL
Intervention: 20-hour multifaceted educational program facilitated by mental health experts
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 15503298

Group type: EXPERIMENTAL
Intervention: Asparaginase dissolved in lidocaine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Asparaginase dissolved in sterile water
Number of subjects: 12
Study: 11963457

Group type: EXPERIMENTAL
Intervention: Cluster-randomized trials
Number of subjects: 0
Study: 10356074

Group type: EXPERIMENTAL
Intervention: 100 g aleurone cereal
Number of subjects: 16

Group type: COMPARATOR
Intervention: 100 g wheat bran cereal (low folate control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 500 microgram folic acid tablet taken with 100 g wheat bran cereal (high folate control)
Number of subjects: 16
Study: 7793586

Group type: EXPERIMENTAL
Intervention: Injection of 0.25 ml of lignocaine 1% via a 25 gauge needle
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Insertion of a 23 gauge Butterfly
Number of subjects: 278

Group type: COMPARATOR
Intervention: Insertion of a 21 gauge Butterfly
Number of subjects: 278

Group type: COMPARATOR
Intervention: Insertion of a 20 gauge Venflon
Number of subjects: 278
Study: 1899735

Group type: EXPERIMENTAL
Intervention: Branched chain amino acid enriched TPN (n = 49)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard TPN (n = 52)
Number of subjects: 101
Study: 6355460

Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine
Number of subjects: 52
Study: 31237871

Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg oral suspension)
Number of subjects: 4724

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4724
Study: 28867538

Group type: EXPERIMENTAL
Intervention: Attention bias modification (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control task (n=30)
Number of subjects: 60
Study: 26511807

Group type: EXPERIMENTAL
Intervention: Pemetrexed-Cisplatin followed by Gefitinib maintenance therapy (PC/G)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Gefitinib monotherapy
Number of subjects: 111
Study: 24296746

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus reuteri)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 21570139

Group type: EXPERIMENTAL
Intervention: High concentration oxygen at 15 L/min via a non-rebreather mask
Number of subjects: 22

Group type: COMPARATOR
Intervention: Air at 15 L/min via a non-rebreather mask
Number of subjects: 22
Study: 19653739

Group type: EXPERIMENTAL
Intervention: Illusory-contour figure as an object mask (created by rotating 4 previewed inducers shaped like Pac-Man)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0
Study: 17580726

Group type: EXPERIMENTAL
Intervention: Hearing aid users
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonusers
Number of subjects: 0
Study: 15177526

Group type: EXPERIMENTAL
Intervention: Frequent nurse visits every 15 days (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with nurse visits every 90 days (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Frequent nurse visits (Group A)
Number of subjects: 100
Study: 11277163

Group type: EXPERIMENTAL
Intervention: Sea-Bands with acupressure buttons applied to both wrists for 4 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sea-Bands without acupressure buttons applied to both wrists for 4 days
Number of subjects: 0
Study: 9850350

Group type: EXPERIMENTAL
Intervention: Continuous NaF 75 mg/day with calcium 1500 mg/day for a mean of 41 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Continuous NaF 50 mg/day with calcium 2000 mg/day for a mean of 15 months (10 with vitamin D, 16 without)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Cyclical low-dose NaF alternating with vitamin D for a mean of 15 months and total treatment duration of 28 months
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (7 patients who did not receive NaF)
Number of subjects: 66
Study: 8033618

Group type: EXPERIMENTAL
Intervention: Microwave tissue coagulation (MTC)
Number of subjects: 300

Group type: COMPARATOR
Intervention: CO2 Laser
Number of subjects: 300
Study: 2926699

Group type: EXPERIMENTAL
Intervention: High intensity aerobic training
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic training
Number of subjects: 109

Group type: COMPARATOR
Intervention: Attention-placebo
Number of subjects: 109

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 109
Study: 4947494

Group type: EXPERIMENTAL
Intervention: Isoniazid 400 mg daily for 1 year (second year maintenance) in patients with residual cavitation.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoniazid 300 mg daily for 6 months (second year maintenance) in patients without residual cavitation.
Number of subjects: 0
Study: 31814153

Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Treatment assignment according to the PTR
Number of subjects: 148

Group type: COMPARATOR
Intervention: Enhanced-care as usual
Number of subjects: 148
Study: 30744686

Group type: EXPERIMENTAL
Intervention: Care delivery interventions
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Large-scale implementation intervention
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Single-site implementation intervention
Number of subjects: 9

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 9
Study: 27758126

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation
Number of subjects: 127
Study: 25326090

Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir 600/100 mg twice daily (n=6)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir 800/100 mg once daily (n=17)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir 600/100 mg once daily (n=1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Unbound darunavir
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Darunavir cord blood/maternal blood ratio
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Viral load close to delivery
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Children tested for HIV
Number of subjects: 24
Study: 23688108

Group type: EXPERIMENTAL
Intervention: I‐BiT™ game
Number of subjects: 75

Group type: COMPARATOR
Intervention: non‐I‐BiT™ game
Number of subjects: 75

Group type: COMPARATOR
Intervention: I‐BiT™ DVD
Number of subjects: 75
Study: 21173171

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) concentrations (ng/mL)
Number of subjects: 493
Study: 18543493

Group type: EXPERIMENTAL
Intervention: NB‐UVB combined with Yuyin Recipe (YYR) bathing
Number of subjects: 119

Group type: COMPARATOR
Intervention: NB‐UVB alone
Number of subjects: 119
Study: 16510944

Group type: EXPERIMENTAL
Intervention: EEG spectral analysis using a novel multi-resolution decomposition algorithm based on Daubechies wavelet transform
Number of subjects: 227

Group type: COMPARATOR
Intervention: Age-matched normal elderly subjects
Number of subjects: 227
Study: 14529800

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: L-dopa
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11252650

Group type: EXPERIMENTAL
Intervention: Calcium channel antagonists (CCAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0
Study: 8653997

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.2 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil (2 microg/kg)
Number of subjects: 60
Study: 1594707

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 3840149

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) to the breast and adjacent lymph node areas
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: RT followed by 12 cycles of cyclophosphamide, methotrexate, 5 fluorouracil (CMF) and tamoxifen
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2 cycles of adriamycin and vincristine (AV), alternated with 2 cycles of CMF, then RT, followed by another 4 cycles of AV, alternated with 4 CMF; tamoxifen during the entire treatment period
Number of subjects: 118
Study: 29792241

Group type: EXPERIMENTAL
Intervention: digital CBT for insomnia (dCBT-I)
Number of subjects: 358

Group type: COMPARATOR
Intervention: online sleep education (control)
Number of subjects: 358
Study: 30268470

Group type: EXPERIMENTAL
Intervention: S-1 monotherapy
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin combination therapy
Number of subjects: 141
Study: 28174456

Group type: EXPERIMENTAL
Intervention: Forced breathing exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trunk stabilization exercises
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: M1 and M2 tests of lumbar spine stabilization
Number of subjects: 24
Study: 25178810

Group type: EXPERIMENTAL
Intervention: Midwife-led care
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Supportive procedures by midwives
Number of subjects: 999

Group type: COMPARATOR
Intervention: Overall rate of spontaneous delivery
Number of subjects: 999
Study: 22221174

Group type: EXPERIMENTAL
Intervention: Smear layer removal (G1)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Smear layer nonremoval (G2)
Number of subjects: 48
Study: 20148607

Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P) program
Number of subjects: 12499

Group type: COMPARATOR
Intervention: Patients not enrolled in the P4P program (Control)
Number of subjects: 12499
Study: 17319365

Group type: EXPERIMENTAL
Intervention: Epinephrine‐impregnated cord
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aluminium chloride‐impregnated cord
Number of subjects: 30
Study: 15760536

Group type: EXPERIMENTAL
Intervention: Cranial hypothermia treatment started within 6 hours (Group A)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cranial hypothermia treatment started in 7-10 hours (Group B)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Cranial hypothermia treatment started in 11-14 hours (Group C)
Number of subjects: 92
Study: 11818757

Group type: EXPERIMENTAL
Intervention: 3% inspired carbon dioxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: 17% inspired oxygen
Number of subjects: 0
Study: 9578193

Group type: EXPERIMENTAL
Intervention: Ropinirole in fasted condition
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ropinirole in fed condition
Number of subjects: 12
Study: 7662568

Group type: EXPERIMENTAL
Intervention: Dithranol 3% in cream, paste and petrolatum applied for 1 hour
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dithranol 3% in cream, paste and petrolatum
Number of subjects: 20
Study: 2651251

Group type: EXPERIMENTAL
Intervention: Gallopamil (3 x 50 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Molsidomine (2 x 2 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gallopamil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Molsidomine
Number of subjects: 20
Study: 319871

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol (4 mug/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aerosol salbutamol (200 mug)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31053509

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (measured by MEDAS)
Number of subjects: 5801
Study: 30928435

Group type: EXPERIMENTAL
Intervention: Low institutional trust
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Belief in misinformation
Number of subjects: 961
Study: 29020300

Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS) with 12 months of dual antiplatelet therapy (DAPT)
Number of subjects: 102735

Group type: EXPERIMENTAL
Intervention: Durable polymer stents (EES/ZES) with DAPT > 12 months
Number of subjects: 102735

Group type: EXPERIMENTAL
Intervention: Durable polymer stents (EES/ZES) with DAPT < 12 months
Number of subjects: 102735

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer stents with 12 months of DAPT
Number of subjects: 102735

Group type: EXPERIMENTAL
Intervention: DAPT > 12 months
Number of subjects: 102735

Group type: COMPARATOR
Intervention: DAPT < 12 months
Number of subjects: 102735
Study: 26046532

Group type: EXPERIMENTAL
Intervention: MGIT960
Number of subjects: 693

Group type: COMPARATOR
Intervention: Lowenstein‐Jensen (LJ)
Number of subjects: 693
Study: 23511682

Group type: EXPERIMENTAL
Intervention: 2.5 mL of contrast medium (Group A)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: 5 mL of contrast medium (Group B)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: 10 mL of contrast medium (Group C)
Number of subjects: 133
Study: 22331686

Group type: EXPERIMENTAL
Intervention: Lauric + myristic acid-rich meal (LM), P/S 0.19
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Palmitic acid-rich meal (POL), P/S 0.31
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stearic acid-rich meal (STE), P/S 0.22
Number of subjects: 20
Study: 19112218

Group type: EXPERIMENTAL
Intervention: External jugular vein catheterization
Number of subjects: 68

Group type: COMPARATOR
Intervention: Other central venous catheterization (internal jugular or subclavian vein)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study: 16720705

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 717

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 717
Study: 15312252

Group type: EXPERIMENTAL
Intervention: 20 mg/day of isosorbide mononitrate (ISMO)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 5 mg/day of isosorbide mononitrate (ISMO)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 10937568

Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: dorzolamide
Number of subjects: 20
Study: 9295846

Group type: EXPERIMENTAL
Intervention: Therapeutic electrical stimulation (TES) for 1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: No TES (control group)
Number of subjects: 0
Study: 8123096

Group type: EXPERIMENTAL
Intervention: Levobunolol b.i.d.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Dipivefrin b.i.d.
Number of subjects: 38
Study: 3470498

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30518633

Group type: EXPERIMENTAL
Intervention: Tumor-infiltrating lymphocyte (TIL) therapy with lymphocyte-depleting conditioning regimen followed by systemic high-dose aldesleukin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tumor-infiltrating lymphocyte (TIL) therapy
Number of subjects: 29
Study: 30585471

Group type: EXPERIMENTAL
Intervention: Electroacupuncture stimulation of abdominal acupoints (CV 13, CV 12, CV 10, ST 21, ST 23, ST 20, SP 16, KI 19) with EA (2 Hz/15 Hz, 1 mA, duration of 30 min) for 5 days.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electroacupuncture stimulation of limb acupoints (LI 4, PC 6, ST 36, ST 37, ST 39, SP 9) with EA (2 Hz/15 Hz, 1 mA, duration of 30 min) for 5 days.
Number of subjects: 60
Study: 26747317

Group type: EXPERIMENTAL
Intervention: SDQ mapping algorithm using five SDQ subscales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SDQ mapping algorithm using three SDQ subscales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original CHU9D tariff
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative CHU9D tariff
Number of subjects: 0
Study: 24480603

Group type: EXPERIMENTAL
Intervention: Massage therapy (moderate pressure stroking)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise (flexion and extension of limbs)
Number of subjects: 30
Study: 22128081

Group type: EXPERIMENTAL
Intervention: Cane use (experimental group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No cane use (control group)
Number of subjects: 64
Study: 20228679

Group type: EXPERIMENTAL
Intervention: Intravenous glucagon‐like peptide‐1 (1.2 pmol/kg/min)
Number of subjects: 25
Study: 17490508

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 36

Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 36
Study: 16088097

Group type: EXPERIMENTAL
Intervention: Ethanol + honey (0.5 g/kg + 1.25 ml/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 50
Study: 12149294

Group type: EXPERIMENTAL
Intervention: Clodronate 1,600 mg/d for 2 years
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Placebo for 2 years
Number of subjects: 1069

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1069
Study: 10235081

Group type: EXPERIMENTAL
Intervention: Chemotherapy (including 5-fluorouracil, gemcitabine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 0
Study: 7869919

Group type: EXPERIMENTAL
Intervention: Three meals per day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Six meals per day
Number of subjects: 12
Study: 2389321

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 363255

Group type: EXPERIMENTAL
Intervention: Radiation therapy to the regional lymph node area following lymphadenectomy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Lymphadenectomy alone
Number of subjects: 56
Study: 31814045

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Prolonged SLED-HDF (12 h)
Number of subjects: 6
Study: 31530615

Group type: EXPERIMENTAL
Intervention: Selective removal (SE)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Stepwise removal (SW)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Selective removal (SE) and Stepwise removal (SW)
Number of subjects: 115
Study: 28236604

Group type: EXPERIMENTAL
Intervention: Prompted Voiding (PV) intervention delivered by nursing home staff for 6 months
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 52
Study: 26168857

Group type: EXPERIMENTAL
Intervention: 5 mg/d lactotripeptides (LTP) and 2 g/d plant sterols
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 25 mg/d lactotripeptides (LTP) and 2 g/d plant sterols
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 24061556

Group type: EXPERIMENTAL
Intervention: Overt Hypothyroidism (OHT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Subclinical Hypothyroidism (SHT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy Volunteers (Control)
Number of subjects: 75
Study: 21861027

Group type: EXPERIMENTAL
Intervention: Hand instrumentation with K‐Flexofiles
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: K‐Flexofiles activated by an oscillatory system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProTaper NiTi rotary system
Number of subjects: 60
Study: 19672567

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day (n=13)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day + MPA 2.5 mg/day (n=14)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day (n=11)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (n=9)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (n=17)
Number of subjects: 64
Study: 17088163

Group type: EXPERIMENTAL
Intervention: Collaborative care for depression (12 months of systematic depression care including antidepressant pharmacotherapy and/or problem-solving treatment)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 1001
Study: 14751370

Group type: EXPERIMENTAL
Intervention: U-Tex
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C3
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cunningham clamp
Number of subjects: 12
Study: 11553203

Group type: EXPERIMENTAL
Intervention: Post-prandial insulin lispro (PL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Human regular insulin (HR)
Number of subjects: 24
Study: 9593041

Group type: EXPERIMENTAL
Intervention: pyrimethamine-sulfadoxine
Number of subjects: 0

Group type: COMPARATOR
Intervention: chlorproguanil-dapsone
Number of subjects: 0
Study: 7869886

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 300 mg.kg‐1
Number of subjects: 7

Group type: COMPARATOR
Intervention: NaCl 207 mg.kg‐1
Number of subjects: 7
Study: 3257532

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim (800 mg and 160 mg twice per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole and trimethoprim
Number of subjects: 60
Study: 30320542

Group type: EXPERIMENTAL
Intervention: Homozygous mutations in PAI-1, MTHFR A1298C, and ACE genes
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: FXIII V34L and PAI-1 4G/5G genotypes
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Genetic, traditional, and total scores
Number of subjects: 102